Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
The Urologic Clinics of North America|April 15, 2026
Treatments on the Horizon for Men with Advanced Prostate CancerMatthew I Ehrlich, Ron S Gejman, Ezra Bernstein, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|October 8, 2025
CD8 co-receptor modulates the specificity profile of the 1G4 TCR against NY-ESO-1Heather F Jones, Zita E H Aretz, Ron S Gejman, et al.Journal of Proteomics|August 8, 2020
An input-controlled model system for identification of MHC bound peptides enabling laboratory comparisons of immunopeptidome experimentsMartin G Klatt, Zita E H Aretz, Michael Curcio, et al.Elife|December 1, 2018
Rejection of immunogenic tumor clones is limited by clonal fractionRon S Gejman, Aaron Y Chang, Heather F Jones, et al.Oncoimmunology|March 5, 2016
T cell receptor mimic antibodies for cancer therapyLeonid Dubrovsky, Tao Dao, Ron S Gejman, et al.Expert Opinion on Biological Therapy|April 21, 2016
Opportunities and challenges for TCR mimic antibodies in cancer therapyAaron Y Chang, Ron S Gejman, Elliott J Brea, et al.Blood Advances|May 13, 2022
Unmasking the suppressed immunopeptidome of EZH2-mutated diffuse large B-cell lymphomas through combination drug treatmentChristopher M Bourne, Sung Soo Mun, Tao Dao, et al.Cancer Immunology Research|March 19, 2020
Identification of the Targets of T-cell Receptor Therapeutic Agents and Cells by Use of a High-Throughput Genetic PlatformRon S Gejman, Heather F Jones, Martin G Klatt, et al.The Journal of Clinical Investigation|June 20, 2017
A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigensAaron Y Chang, Tao Dao, Ron S Gejman, et al.Transplantation Proceedings|February 28, 2025
Case Report: A Unique Case of Hemophagocytic Lymphohistiocytosis in Heart TransplantBoaz Elad, Wojciech Rzechorzek, Kelly Axsom, et al.Pageof 2